Observational studyMedicine2015

Sox17 promoter methylation in plasma DNA is associated with poor survival and can be used as a prognostic factor in breast cancer.

Deyuan Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.